Macromoltek
Computational antibody design
About
Macromoltek: Revolutionizing antibody design.
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Topics
- Location
- Austin, TX, United States
- Team size
- 14 employees
- YC batch
- Winter 2018
- Status
- Active
- Stage
- Early stage
